S. Ferrucci

Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study

G. Fabbrocini, G. Pellacani, C. Foti, 2021, Archives of Dermatological Research.

Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis

I. Zalaudek, G. Argenziano, C. Patruno, 2019, The Journal of dermatological treatment.

Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study

G. Argenziano, G. Fabbrocini, M. Napolitano, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response

G. Fabbrocini, C. Patruno, G. Pellacani, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis

I. Zalaudek, G. Argenziano, C. Patruno, 2020, The Journal of dermatological treatment.

A 52‐week update of a multicentre Italian real‐world experience on effectiveness and safety of dupilumab in adolescents with moderate‐to‐severe atopic dermatitis

G. Fabbrocini, M. Napolitano, C. Patruno, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Moderate‐to‐severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real‐world experience

G. Fabbrocini, M. Napolitano, C. Patruno, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study

G. Fabbrocini, G. Pellacani, C. Foti, 2021, Archives of Dermatological Research.

A Multicenter Study on the Prevalence of Clinical Patterns and Clinical Phenotypes in Adult Atopic Dermatitis

G. Pellacani, D. Bona, Tavecchio, 2020 .

Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study

A. Balato, S. Ribero, M. Galluzzo, 2023, Expert opinion on biological therapy.